These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11676143)

  • 1. [Thromboxane A2 synthase inhibitor and receptor antagonist].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1986-91. PubMed ID: 11676143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K; Takagi K; Horiba M
    Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma.
    Obase Y; Shimoda T; Matsuo N; Matsuse H; Asai S; Kohno S
    Chest; 1998 Oct; 114(4):1028-32. PubMed ID: 9792572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thromboxane A2 receptor antagonist in asthma therapy].
    Endo S; Akiyama K
    Nihon Rinsho; 1996 Nov; 54(11):3045-8. PubMed ID: 8950952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2 inhibition: therapeutic potential in bronchial asthma.
    Dogné JM; de Leval X; Benoit P; Delarge J; Masereel B
    Am J Respir Med; 2002; 1(1):11-7. PubMed ID: 14720071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostanoids as pharmacological targets in COPD and asthma.
    Rolin S; Masereel B; Dogné JM
    Eur J Pharmacol; 2006 Mar; 533(1-3):89-100. PubMed ID: 16458293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2 and related prostaglandins in airways.
    Devillier P; Bessard G
    Fundam Clin Pharmacol; 1997; 11(1):2-18. PubMed ID: 9182072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of thromboxane A2 synthetase inhibitor (OKY-046) on leukotriene C4-induced airway hyperresponsiveness in guinea pigs].
    Tsukagoshi H; Yodonawa S; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jun; 31(6):707-11. PubMed ID: 8345703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of seratrodast on eosinophil cationic protein and symptoms in asthmatics.
    Fukuoka T; Miyake S; Umino T; Inase N; Tojo N; Yoshizawa Y
    J Asthma; 2003 May; 40(3):257-64. PubMed ID: 12807169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modulation of immediate and late airway response and leukocyte infiltration in the guinea pig.
    Matsumoto T; Ashida Y; Tsukuda R
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1236-44. PubMed ID: 8014867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice.
    Shi H; Yokoyama A; Kohno N; Hirasawa Y; Kondo K; Sakai K; Hiwada K
    Eur Respir J; 1998 Mar; 11(3):624-9. PubMed ID: 9596113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of antigen-induced airway hyperresponsiveness by thromboxane A2 inhibitors in guinea pigs.
    Nagai H; Tsuji F; Goto S; Koda A
    Biol Pharm Bull; 1993 Nov; 16(11):1099-103. PubMed ID: 8312863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of a specific thromboxane A2 antagonist, AA-2414 on airway hyperresponsiveness induced by ozone exposure in dogs].
    Imai T; Adachi M; Idaira K; Suganuma T; Takahashi T; Yamaguchi H; Saito C; Maeda M; Tsuji A
    Arerugi; 1991 Jan; 40(1):28-36. PubMed ID: 1827576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the usefulness of thromboxane-A2 modulation in the treatment of bronchoconstriction in asthma.
    Hernandez JM; Janssen LJ
    Can J Physiol Pharmacol; 2015 Feb; 93(2):111-7. PubMed ID: 25581104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thromboxane A2 (TXA2) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs.
    Yoshimi Y; Fujimura M; Myou S; Tachibana H; Hirose T
    Prostaglandins Other Lipid Mediat; 2001 May; 65(1):1-9. PubMed ID: 11352222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Matsuura M; Kawakami Y; Terasawa M
    Inflamm Res; 1997 Apr; 46(4):147-53. PubMed ID: 9137994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma.
    Hoshino M; Sim J; Shimizu K; Nakayama H; Koya A
    J Allergy Clin Immunol; 1999 Jun; 103(6):1054-61. PubMed ID: 10359886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients].
    Muramatsu H; Kotajima R; Sato T
    Arerugi; 2001 Jun; 50(6):540-6. PubMed ID: 11517517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2 synthetase inhibitor (OKY-046) improves abnormal mucociliary transport in asthmatic patients.
    Kurashima K; Ogawa H; Ohka T; Fujimura M; Matsuda T
    Ann Allergy; 1992 Jan; 68(1):53-6. PubMed ID: 1736720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.